← Leaderboards
Bradley K Taylor
University Of Pittsburgh At Pittsburgh
$17,950,936
Attributed
$19,474,719
Total exposure
11
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,474,719 · 11
By mechanism
R01$16,581,719 · 4
K02$573,970 · 1
R21$550,412 · 1
R15$451,522 · 1
R29$382,075 · 1
R56$336,438 · 1
Top collaborators
- Patrick L Sheets5 shared
- Stephen M. Onifer1 shared
- Jami Lynn Saloman1 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Tony M Plant$8,137,866
Others in their field
Top investigators on “Pain”
- Emer Leahy · Psychogenics, Inc.$49,781,254
- Lynn Larson Debar · Kaiser Foundation Research Institute$37,527,482
- J Richard Landis · University Of Pennsylvania$34,799,488
- Clifford J Woolf · Boston Children'S Hospital$30,992,766
- Emeran A Mayer · University Of California Los Angeles$29,229,798
- Pamela Susan Douglas · Duke University$28,862,172
Research focus
PainNeuronsInflammationMediatingChronic PainReceptorAgonistNerve InjurySpinalBehavioralAnalgesicsDorsal HornPainful NeuropathySignal TransductionHyperalgesiaInjuryTransmission ProcessMechanicsBehaviorPosterior Horn CellsSpinal CordStimulusMolecularReceptor Activation
Grant awards (62)
Neuropeptidergic Inhibition of Spinal Pain Transmission$497,347
R01 · FY2025 · NS · contact PI
Training in Mechanisms and Clinical Presentation of Pain$301,496
T32 · FY2025 · NS · contact PI
Neuropeptidergic Inhibition of Spinal Pain Transmission$482,428
R01 · FY2024 · NS · contact PI
Lipid signaling in supraspinal pain pathways$446,505
R01 · FY2024 · NS
Neuropeptidergic Inhibition of Spinal Pain Transmission$497,347
R01 · FY2023 · NS · contact PI
Lipid signaling in supraspinal pain pathways$460,316
R01 · FY2023 · NS
Neuropeptidergic Inhibition of Spinal Pain Transmission$505,161
R01 · FY2022 · NS · contact PI
Lipid signaling in supraspinal pain pathways$457,701
R01 · FY2022 · NS
Lipid signaling in supraspinal pain pathways$457,701
R01 · FY2021 · NS
PPAR inhibition of spinal pain transmission$455,478
R01 · FY2021 · NS · contact PI
Neuropeptidergic Inhibition of Spinal Pain Transmission$451,283
R01 · FY2021 · NS · contact PI
Lipid signaling in supraspinal pain pathways$472,326
R01 · FY2020 · NS
PPAR inhibition of spinal pain transmission$459,102
R01 · FY2020 · NS · contact PI
Neuropeptidergic Inhibition of Spinal Pain Transmission$451,345
R01 · FY2020 · NS · contact PI
Long-term activation of spinal opioid analgesia after inflammation$586,501
R01 · FY2019 · DA · contact PI
PPAR inhibition of spinal pain transmission$475,267
R01 · FY2019 · NS · contact PI
Neuropeptidergic Inhibition of Spinal Pain Transmission$451,406
R01 · FY2019 · NS · contact PI
Long-term activation of spinal opioid analgesia after imflammation - Supplement$392,266
R01 · FY2019 · DA · contact PI
Long-term activation of spinal opioid analgesia after inflammation$600,702
R01 · FY2018 · DA · contact PI
PPAR inhibition of spinal pain transmission$384,300
R01 · FY2018 · NS · contact PI
Neuropeptidergic Inhibition of Spinal Pain Transmission$330,180
R01 · FY2018 · NS · contact PI
Neuropeptidergic Inhibition of Spinal Pain Transmission$97,817
R01 · FY2018 · NS · contact PI
PPAR inhibition of spinal pain transmission$75,565
R01 · FY2018 · NS · contact PI
Long-term activation of spinal opioid analgesia after inflammation$592,232
R01 · FY2017 · DA · contact PI
PPAR inhibition of spinal pain transmission$523,837
R01 · FY2017 · NS · contact PI
Antinociceptive Mechanisms of Spinal Manipulative Therapy for Neuropathic Pain$451,522
R15 · FY2017 · AT
Neuropeptidergic Inhibition of Spinal Pain Transmission$440,622
R01 · FY2017 · NS · contact PI
Long-term activation of spinal opioid analgesia after inflammation$590,098
R01 · FY2016 · DA · contact PI
Long-term activation of spinal opioid analgesia after inflammation$610,188
R01 · FY2015 · DA · contact PI
PPAR Inhibition of Spinal Pain Transmission$307,205
R01 · FY2013 · NS · contact PI
Neuropeptidergic Inhibition of Spinal Pain Transmission$307,205
R01 · FY2013 · NS · contact PI
PPAR Inhibition of Spinal Pain Transmission$318,347
R01 · FY2012 · NS · contact PI
Neuropeptidergic Inhibition of Spinal Pain Transmission$303,127
R01 · FY2012 · NS · contact PI
PPAR Inhibition of Spinal Pain Transmission$318,347
R01 · FY2011 · NS · contact PI
Neuropeptidergic Inhibition of Spinal Pain Transmission$313,846
R01 · FY2011 · NS · contact PI
Neuropeptidergic Inhibition of Spinal Pain Transmission$123,298
K02 · FY2011 · DA · contact PI
Neuropeptidergic Inhibition of Spinal Pain Transmission$341,469
R01 · FY2010 · NS · contact PI
PPAR Inhibition of Spinal Pain Transmission$321,596
R01 · FY2010 · NS · contact PI
Olympus BX-DSU Live-Cell Disk Scanning Imaging / Electrophysiology System$297,087
S10 · FY2010 · RR · contact PI
Neuropeptidergic Inhibition of Spinal Pain Transmission$123,298
K02 · FY2010 · DA · contact PI
PPAR Inhibition of Spinal Pain Transmission$323,568
R01 · FY2009 · NS · contact PI
Neuropeptidergic Inhibition of Spinal Pain Transmission$123,298
K02 · FY2009 · DA · contact PI
Neuropeptidergic Inhibition of Spinal Pain Transmission$297,996
R56 · FY2008 · NS · contact PI
Neuropeptidergic Inhibition of Spinal Pain Transmission$70,200
K02 · FY2008 · DA · contact PI
Neuropeptidergic Inhibition of Spinal Pain Transmission$38,442
R56 · FY2008 · NS · contact PI
Neuropeptidergic Inhibition of Spinal Pain Transmission$33,346
K02 · FY2008 · DA · contact PI
NEUROPEPTIDERGIC INHIBITION OF SPINAL PAIN TRANSMISSION$208,600
R01 · FY2007 · NS · contact PI
Neuropeptidergic Inhibition of Spinal Pain Transmission$100,530
K02 · FY2007 · DA · contact PI
Supraspinal Modulation of Neuropathic Pain$77,650
R21 · FY2007 · DA · contact PI
Supraspinal Modulation of Neuropathic Pain$1,923
R21 · FY2007 · DA · contact PI
Supraspinal Modulation of Neuropathic Pain$181,264
R21 · FY2006 · DA · contact PI
NEUROPEPTIDERGIC INHIBITION OF SPINAL PAIN TRANSMISSION$74,250
R01 · FY2006 · NS · contact PI
Supraspinal Modulation of Neuropathic Pain$66,825
R21 · FY2006 · DA · contact PI
NEUROPEPTIDERGIC INHIBITION OF SPINAL PAIN TRANSMISSION$282,150
R01 · FY2005 · NS
Supraspinal Modulation of Neuropathic Pain$222,750
R21 · FY2005 · DA
NEUROPEPTIDERGIC INHIBITION OF SPINAL PAIN TRANSMISSION$282,150
R01 · FY2004 · NS
NEUROPEPTIDERGIC INHIBITION OF SPINAL PAIN TRANSMISSION$282,150
R01 · FY2003 · NS
NEUROPEPTIDERGIC INHIBITION OF SPINAL PAIN TRANSMISSION$352,688
R01 · FY2002 · NS
PAIN, OPIOID ANALGESIA AND BLOOD PRESSURE CONTROL$95,278
R29 · FY2002 · DA
PAIN, OPIOID ANALGESIA AND BLOOD PRESSURE CONTROL$160,301
R29 · FY2001 · DA
PAIN, OPIOID ANALGESIA AND BLOOD PRESSURE CONTROL$99,498
R29 · FY2000 · DA
PAIN, OPIOID ANALGESIA AND BLOOD PRESSURE CONTROL$26,998
R29 · FY2000 · DA